Your browser doesn't support javascript.
loading
Chromothripsis is a frequent event and underlies typical genetic changes in early T-cell precursor lymphoblastic leukemia in adults.
Arniani, Silvia; Pierini, Valentina; Pellanera, Fabrizia; Matteucci, Caterina; Di Giacomo, Danika; Bardelli, Valentina; Quintini, Martina; Mavridou, Elena; Lema Fernandez, Anair Graciela; Nardelli, Carlotta; Moretti, Martina; Gorello, Paolo; Crescenzi, Barbara; Romoli, Silvia; Beacci, Donatella; Cerrano, Marco; Fracchiolla, Nicola; Sica, Simona; Forghieri, Fabio; Giglio, Fabio; Dargenio, Michela; Elia, Loredana; La Starza, Roberta; Mecucci, Cristina.
Afiliación
  • Arniani S; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Pierini V; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Pellanera F; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Matteucci C; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Di Giacomo D; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Bardelli V; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Quintini M; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Mavridou E; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Lema Fernandez AG; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Nardelli C; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Moretti M; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Gorello P; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Crescenzi B; Department of Chemistry, Biology and Biotechnology, University of Perugia, Perugia, Italy.
  • Romoli S; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Beacci D; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Cerrano M; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Fracchiolla N; MC: Division of Hematology, Department of Oncology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.
  • Sica S; UOC Ematologia, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
  • Forghieri F; Department of Diagnosis, Oncologic and Hematologic Radiotherapy, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Giglio F; Hematology Division, Department of Oncology and Hematology, A.O.U of Modena-Policlinico, Modena, Italy.
  • Dargenio M; Haematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Elia L; Hematology, Department of Translational and Precision Medicine, S.C. Ematologia, Ospedale Vito Fazzi, Lecce, Italy.
  • La Starza R; Division of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • Mecucci C; Department of Medicine and Surgery, Center for Hemato-Oncology Research (CREO), Hematology and Bone Marrow Transplantation Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy. roberta.lastarza@unipg.it.
Leukemia ; 36(11): 2577-2585, 2022 11.
Article en En | MEDLINE | ID: mdl-35974102
ABSTRACT
Chromothripsis is a mitotic catastrophe that arises from multiple double strand breaks and incorrect re-joining of one or a few chromosomes. We report on incidence, distribution, and features of chromothriptic events in T-cell acute lymphoblastic leukemias (T-ALL). SNP array was performed in 103 T-ALL (39 ETP/near ETP, 59 non-ETP, and 5 with unknown stage of differentiation), including 38 children and 65 adults. Chromothripsis was detected in 11.6% of all T-ALL and occurred only in adult cases with an immature phenotype (12/39 cases; 30%). It affected 1 to 4 chromosomes, and recurrently involved chromosomes 1, 6, 7, and 17. Abnormalities of genes typically associated with T-ALL were found at breakpoints of chromothripsis. In addition, it gave rise to new/rare alterations, such as, the SFPQZFP36L2 fusion, reported in pediatric T-ALL, deletions of putative suppressors, such as IKZF2 and CSMD1, and amplification of the BCL2 gene. Compared to negative cases, chromothripsis positive T-ALL had a significantly higher level of MYCN expression, and a significant downregulation of RGCC, which is typically induced by TP53 in response to DNA damage. Furthermore we identified mutations and/or deletions of DNA repair/genome stability genes in all cases, and an association with NUP214 rearrangements in 33% of cases.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Precursoras de Linfocitos T / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Cromotripsis Límite: Adult / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Precursoras de Linfocitos T / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Cromotripsis Límite: Adult / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Italia